JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Doorn, L.-J.
Right arrow Articles by Colau, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Doorn, L.-J.
Right arrow Articles by Colau, B.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, September 2006, p. 3292-3298, Vol. 44, No. 9
0095-1137/06/$08.00+0     doi:10.1128/JCM.00539-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Highly Effective Detection of Human Papillomavirus 16 and 18 DNA by a Testing Algorithm Combining Broad-Spectrum and Type-Specific PCR

Leen-Jan van Doorn,1* Anco Molijn,1 Bernhard Kleter,1 Wim Quint,1 and Brigitte Colau2

DDL Diagnostic Laboratory, Fonteijnenburghlaan 5, Voorburg, The Netherlands,1 GSK Biologicals, Rue de l'Institut 89, Rixensart, Belgium2

Received 13 March 2006/ Returned for modification 8 June 2006/ Accepted 19 June 2006

The use of a single broad-spectrum human papillomavirus (HPV) DNA-based PCR test may fail to detect lower concentrations of HPV DNA due to competition between different genotypes in mixed infections. To improve HPV detection by PCR, broad-spectrum and type-specific (TS) PCRs were combined, with a focus on HPV-16 and HPV-18. Cervical and cervicovaginal cell samples were obtained from 1,113 healthy women (age range, 15 to 25 years) participating in an HPV-16/HPV-18 candidate vaccine efficacy trial. These samples were tested by a broad-spectrum SPF10 PCR-DNA enzyme immunoassay, followed by a primer SPF10-based line probe assay (SPF10 LiPA), and HPV-16- and HPV-18-TS PCRs. The results for the majority of the HPV-16/18 SPF10 LiPA-positive samples were confirmed by TS-PCR (kappa values, 0.775 for HPV-16 and 0.785 for HPV-18). However, TS PCR revealed additional positive samples among those that contained other HPV genotypes due to competition. Conversely, SPF10 LiPA identified HPV-16 or -18 in samples that remained negative by TS PCR as a result of sampling variation. Analysis of follow-up samples from more than 1,000 women confirmed that the combination of SPF10-LiPA with additional HPV-16- and HPV-18-TS PCR diminishes the rate of false-negative diagnosis. The combination of broad-spectrum and TS PCRs resulted in a novel testing algorithm. This combination of assays is more accurate than either method alone, and the novel algorithm offers a highly accurate and effective method for the analysis of HPV infections.


* Corresponding author. Mailing address: DDL Diagnostic Laboratory, Fonteijnenburghlaan 5, 2275 CX, Voorburg, The Netherlands. Phone: 31-70-3401670. Fax: 31-70-3401671. E-mail: L.J.van.Doorn{at}ddl.nl.


Journal of Clinical Microbiology, September 2006, p. 3292-3298, Vol. 44, No. 9
0095-1137/06/$08.00+0     doi:10.1128/JCM.00539-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2006 by the American Society for Microbiology. All rights reserved.